CCL23 and early-onset autosomal dominant Alzheimer disease: Additionally, the involvement of CCL23 in neuroinflammation associated with neurodegenerative diseases such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) also provides corresponding evidence (58, 60).